Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eMagin Corporation is a leading developer and manufacturer of high-resolution active-matrix Organic LED (OLED) microdisplays on silicon. The company's proprietary Direct Patterning Technology (dPd) allows for the creation of ultra-bright, high-contrast displays that are essential for near-eye imaging applications in the medical, military, and industrial sectors. In the healthcare space, eMagin's technology is utilized in surgical headsets, endoscopes, and advanced medical imaging systems to provide clinicians with high-fidelity visual data. Headquartered in Hopewell Junction, New York, eMagin is the only manufacturer of OLED microdisplays in the United States. The company was acquired by Samsung Display in October 2023 for approximately $218 million and now operates as a subsidiary.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eMagin.